Menu
Funding avenues
Menu
| Name | Description | Relevant Grants | Timing |
|---|---|---|---|
| National MS Society | The National MS Society (NMSS), United States, supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation through various funding schemes for research into MS. NMSS offers Research Grants for scientists and clinicians of up to 3 years, Pilot Research Grants for one year, and range of Training Grants and Fellowships. The Fast Forward program for commercial research funding targets funds to de-risk therapeutic development; with academic researchers and companies eligible to apply. Â Applications are accepted from non-US citizens, but applicants are encouraged to apply to other granting agencies in their own country. Details on eligibility for individual awards can be found here. | People Support:
|
Varied. |
| National Institute for Health | The National Institutes of Health (NIH) are part of the U.S. Department of Health and Human Services. NIH is the largest source of funding for medical research in the world, funding thousands of scientists in universities and research institutions around the globe. NIH’s grants and funding program includes Research Grants, Awards, Research Training and Fellowships, Project/Centre Grants, and Resource Grants. Many NIH grants are available to Australian investigators and organisations; see here for more information on foreign eligibility. | People Support:
|
Varied. |
| MS International Federation | The MS International Federation (MSIF) funds and facilitates international collaboration on research into the understanding, treatment and cure of MS. The MSIF offers a Young Researcher Award for the best oral presentation of a translational project by a young researcher at the meeting of the European Committee for Treatment and Research in MS (ECTRIMS) each year. They give the Charcot Award every two years for a lifetime of achievement in outstanding research into the understanding or treatment of MS; with the Charcot Lecture presented by the recipient at ECTRIMS. Historically the McDonald Fellowship has been funded annually to allow young researchers from low- and middle-income countries for a 2-year placement in an overseas research institution with the aim of returning to their country to establish an MS research program. They also offer the Du Pré Grant to MS researchers and clinicians from low- and middle-income countries to make short visits (under six months) to established MS research centres outside of their own country. Due to travel restrictions with the global pandemic, MSIF has considered alternative ways to carry out research projects allowing flexibility around how the McDonald Fellowship and Du Pré Grants are spent, as well as when and where the project would be carried out; see here for updated details. | People Support:
|
Varied. The Young Researchers Award and Charcot Award are awarded at the ECTRIMS meeting. The McDonald Fellowship and Du Pré Grant are awarded in September/October each year. |
| International Progressive MS Alliance | The International Progressive MS Alliance periodically offers Research Challenge awards. These project grants are for up to €75,000 in total costs for 12 months and projects must focus that focus on identifying new understandings into the cause of progression and help identify new paths for treatment development. Innovation and multi-national collaboration are key elements of these grants. Research Challenges Awards Rounds were granted in 2014 and 2020 for 2021. In 2017, the Alliance also offered three large multi-year grants to collaborative networks of international MS researchers to lead the fight against progressive MS. Each grant was for €4.2 million to run over four years. In 2023, the Alliance requested applications to provide funding for a research pipeline to test innovative outcomes or treatments focused on the well-being of people living with progressive MS. Successful awards will demonstrate a strong expert team that offers the potential for novel therapeutic interventions or outcomes for progressive MS (Stage 1) and has the potential to culminate with a large randomiSed controlled study (Stage 2) and implementation (Stage 3) for adoption into the larger healthcare system. Stage 1 is a planning grant of up to €100,000 that provides time and resources to develop ideas, collect preliminary data (if needed), and construct a research team to develop and present an efficacy research proposal. | Project or Infrastructure:
|
Varied. Please check the Alliance website here for updates. |
| European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) | ECTRIMS is a non-profit, independent, representative European-wide organisation that serves as Europe’s and the world’s largest professional organisation dedicated to the understanding and treatment of multiple sclerosis. ECTRIMS offers a postdoctoral research fellowship exchange programme for young neuroscientists to facilitate their conduct of and training in basic, clinical or applied research related to multiple sclerosis (MS). The goal of the programme is to maximize exchange of information and to help grow the pool of well-trained research scientists focused on problems in MS. Citizens of any country are eligible to apply to this programme; however, postdoctoral research training must be undertaken in a European laboratory or clinic. ECTRIMS also co-funds the MSIF McDonald Fellowship. | Project or Infrastructure:
|
Applications must be submitted online by 1 Dec each year. |
